Patent details

EP2853272 Title: Therapeutic use of anti-CS1 antibodies

Basic Information

Publication number:
EP2853272
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP141780619
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Therapeutic use of anti-CS1 antibodies
French Title of Invention:
Utilisation thérapeutique d'anticorps anti-CS1
German Title of Invention:
Therapeutische Verwendung von Anti-CS1-Antikörpern
SPC Number:

Dates

Filing date:
10/05/2004
Grant date:
02/08/2017
EP Publication Date:
01/04/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/08/2017
EP B1 Publication Date:
02/08/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
10/05/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/08/2017
 
 

Name:
AbbVie Biotherapeutics Inc.
Address:
1500 Seaport Boulevard, Redwood City, CA 94063, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
30/08/2017
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
LANDOLFI, Nicolas F.
Address:
United States (US)

2

Name:
LIU, Gao
Address:
United States (US)

3

Name:
TSO, Yun J.
Address:
United States (US)

4

Name:
WILLIAMS, Marna
Address:
United States (US)

5

Name:
POWERS, David B.
Address:
United States (US)

Priority

1

Priority Number:
469211 P
Priority Date:
08/05/2003
Priority Country:
United States (US)

2

Priority Number:
557620 P
Priority Date:
29/03/2004
Priority Country:
United States (US)

3

Priority Number:
557621 P
Priority Date:
29/03/2004
Priority Country:
United States (US)

4

Priority Number:
557622 P
Priority Date:
29/03/2004
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61P 35/00; A61P 37/00; C07K 16/28; C12N 5/20;

Publication

European Patent Bulletin

Issue number:
201731
Publication date:
02/08/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/04/2023
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
05/09/2017 Outgoing Correspondence 1
30/08/2017 Power Of Attorney 2